On July 26, 2023, FDA released a guidance document on a program at FDA’s Center for Drug Evaluation and Research (CDER) to publicize a listing of accepted voluntary consensus standards…
Together, we will continue scaling up our activities in the countries of Central Asia. The role of Reka-Med is a production site that will meet the demand for YURіА-PHARM products…